University of Manchester Receives £1 Million to Develop Snail-Inspired Soft Robots for Bowel Cancer Drug Delivery
Key Insights
Researchers at The University of Manchester have secured nearly £1 million in funding from UK Research and Innovation (search) to develop miniature soft robots inspired by snail locomotion for precise bowel cancer (search) drug delivery.
The bio-inspired robots are designed to anchor themselves within malignant tissue and release therapeutic payloads in a controlled manner, potentially improving drug concentration at tumor sites (search) while reducing off-target toxicity.
The project combines biology, materials science, and robotics to address the challenge of navigating complex environments like the gastrointestinal tract with high accuracy for targeted anti-cancer therapies.
Researchers at The University of Manchester have received nearly £1 million in funding from UK Research and Innovation (search) to develop revolutionary soft robots inspired by snail locomotion for precise bowel cancer (search) drug delivery. The project represents a significant advancement in targeted cancer therapy, addressing long-standing challenges in drug delivery precision within the gastrointestinal tract.
Current drug delivery methods often struggle to target tumors accurately, causing side effects in healthy tissue. The new approach aims to release drugs only where needed, increasing effectiveness while reducing harm to the rest of the body. The robots are designed to anchor themselves within malignant tissue and release therapeutic payloads in a controlled way, potentially improving drug concentration at tumor sites (search) and reducing off-target toxicity.
Bio-Inspired Design and Movement
The research team is drawing inspiration from snails and slugs, which move using slow, controlled waves and adhesive mucus. This natural mechanism allows them to travel across uneven and slippery surfaces. By replicating this motion, the researchers aim to build robots that can move precisely inside the human body, with the design focusing on slime-based locomotion powered by rhythmic movement.
"This research brings together biology, materials science and robotics in a way that could genuinely transform future cancer therapies," said Dr Mostafa Nabawy, highlighting the interdisciplinary nature of the project.
The researchers will generate high-resolution datasets capturing how snails move, including their muscle-driven wave patterns and interactions with mucus. These measurements will be used to build machine learning models that can replicate and refine the robots' movement.
Advanced Materials and Control Systems
The soft robots will be constructed using peptide-based bionanomaterials that can be precisely tuned at the molecular level. These materials are designed to respond to external triggers such as magnetic fields, enabling non-invasive control once the robots are inside the body. This level of control could allow clinicians to guide the robots to specific sites and adjust their behavior in real time.
A digital twin framework is being developed to simulate how the robots interact with human tissue before real-world testing. This approach could reduce development time and improve design accuracy, ensuring safer and more effective deployment in clinical settings.
Broader Applications and Future Potential
Beyond cancer treatment, the technology shows promise for multiple applications. Potential uses include alternatives to capsule endoscopy, industrial inspection in confined spaces, and environmental monitoring. The project reflects a broader push toward combining biology and engineering to solve real-world healthcare challenges.
The long-term goal is to create a new class of soft robots capable of operating safely in complex and sensitive environments. The focus remains on improving precision, control, and adaptability in medical applications, particularly for patients with bowel cancer (search) who could benefit from more targeted therapeutic interventions.